A Retrospective, Multi-Center, Observational Study to Assess the Effect of Tecfidera® Delayed-Release Capsules on Lymphocyte Subsets in Subjects with Relapsing Forms of Multiple Sclerosis (REALIZE) First published 24/10/2016 Last updated 01/04/2024 EU PAS number:EUPAS9336 Study Finalised